Novanta Shares Fall After Co. Plans Cost Cuts to Offset Tariffs

Dow Jones
May 06, 2025
 

By Rob Curran

 

Novanta shares fell sharply after the maker of life-sciences equipment warned of a cost-cutting push to offset a likely blow to sales from tariffs, illustrating challenges to exporters posed by the trade war.

The Bedford, Mass., company logged earnings of $21.2 million, or 59 cents a share, up from $14.7 million, or 41 cents a share, a year earlier.

First-quarter revenue rose 1.1% to $233.4 million.

For the second quarter, the company targeted adjusted earnings of 68 cents-to-78 cents a share on revenue in a range between $230 million and $240 million.

"Due to the limited visibility of rapid trade policy changes, and the heightened uncertainty caused by the global trade disruptions, we are in an environment that makes long-term revenue predictions challenging beyond the second quarter," said Chair and Chief Executive Matthijs Glastra, in a statement.

To offset the impact of shifting trade policy, and potential purchase deferrals by customers due to reciprocal tariffs on its products, the company plans "cost containment actions," with a view to reducing costs by $20 million a year.

Shares fell 12% to $105.01 premarket.

 

Write to Rob Curran at rob.curran@wsj.com

 

(END) Dow Jones Newswires

May 06, 2025 08:38 ET (12:38 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10